These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 10608352

  • 1. Adenovirus lacking the 19-kDa and 55-kDa E1B genes exerts a marked cytotoxic effect in human malignant cells.
    Duque PM, Alonso C, Sánchez-Prieto R, Lleonart M, Martínez C, de Buitrago GG, Cano A, Quintanilla M, Ramon y Cajal S.
    Cancer Gene Ther; 1999; 6(6):554-63. PubMed ID: 10608352
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
    Kim J, Cho JY, Kim JH, Jung KC, Yun CO.
    Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
    [Abstract] [Full Text] [Related]

  • 3. E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer.
    Fukuda K, Abei M, Ugai H, Seo E, Wakayama M, Murata T, Todoroki T, Tanaka N, Hamada H, Yokoyama KK.
    Cancer Res; 2003 Aug 01; 63(15):4434-40. PubMed ID: 12907616
    [Abstract] [Full Text] [Related]

  • 4. Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
    Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Terrier-Lacombe MJ, Bressac De-Paillerets B, Barrois M, Feunteun J, Kirn DH, Vassal G.
    Cancer Res; 2002 Feb 01; 62(3):764-72. PubMed ID: 11830531
    [Abstract] [Full Text] [Related]

  • 5. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y, Yu DC, Chen Y, Amin P, Zhang H, Nguyen N, Henderson DR.
    Cancer Res; 2001 Sep 01; 61(17):6428-36. PubMed ID: 11522637
    [Abstract] [Full Text] [Related]

  • 6. Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect.
    Kim J, Kim PH, Yoo JY, Yoon AR, Choi HJ, Seong J, Kim IW, Kim JH, Yun CO.
    Gene Ther; 2009 Sep 01; 16(9):1111-21. PubMed ID: 19494843
    [Abstract] [Full Text] [Related]

  • 7. p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.
    Vollmer CM, Ribas A, Butterfield LH, Dissette VB, Andrews KJ, Eilber FC, Montejo LD, Chen AY, Hu B, Glaspy JA, McBride WH, Economou JS.
    Cancer Res; 1999 Sep 01; 59(17):4369-74. PubMed ID: 10485485
    [Abstract] [Full Text] [Related]

  • 8. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O, Morris JC.
    Cancer Res; 2000 Aug 01; 60(15):4167-74. PubMed ID: 10945625
    [Abstract] [Full Text] [Related]

  • 9. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X, Jung C, Liu YH, Bae KH, Zhang YP, Zhang HJ, Vanderputten D, Jeng MH, Gardner TA, Kao C.
    J Gene Med; 2006 Jun 01; 8(6):679-89. PubMed ID: 16570242
    [Abstract] [Full Text] [Related]

  • 10. E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies.
    Wang G, Li G, Liu H, Yang C, Yang X, Jin J, Liu X, Qian Q, Qian W.
    J Gene Med; 2009 Jun 01; 11(6):477-85. PubMed ID: 19340843
    [Abstract] [Full Text] [Related]

  • 11. The cytotoxic effect of E1B 55-kDa mutant adenovirus on human hepatocellular carcinoma cell lines.
    Zhao J, Wang H, Wei L, Habib NA, Lu X, Wu M, Guo Y.
    Cancer Gene Ther; 2001 May 01; 8(5):333-41. PubMed ID: 11477453
    [Abstract] [Full Text] [Related]

  • 12. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
    Umeoka T, Kawashima T, Kagawa S, Teraishi F, Taki M, Nishizaki M, Kyo S, Nagai K, Urata Y, Tanaka N, Fujiwara T.
    Cancer Res; 2004 Sep 01; 64(17):6259-65. PubMed ID: 15342413
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC, Nie MM, Yang JM, Su CQ, Sun LC, Qian YZ, Sham J, Fang GE, Wu MC, Qian QJ.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):943-8. PubMed ID: 15329284
    [Abstract] [Full Text] [Related]

  • 14. [Variants of adenovirus type 5 with deletions in early genes: ability for selective replication in p53-defective human tumor cells].
    Kachko AV, Sviatchenko VA, Ternovoĭ VA, Kiselev NN, Sorokin AV, Kiselev SL, Georgiev GP, Netesov SV.
    Mol Biol (Mosk); 2003 Jun 02; 37(5):868-75. PubMed ID: 14593924
    [Abstract] [Full Text] [Related]

  • 15. The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells.
    Steegenga WT, Riteco N, Jochemsen AG, Fallaux FJ, Bos JL.
    Oncogene; 1998 Jan 22; 16(3):349-57. PubMed ID: 9467960
    [Abstract] [Full Text] [Related]

  • 16. Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis.
    Ganly I, Kim YT, Hann B, Balmain A, Brown R.
    Gene Ther; 2001 Mar 22; 8(5):369-75. PubMed ID: 11313813
    [Abstract] [Full Text] [Related]

  • 17. ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.
    Yun CO, Kim E, Koo T, Kim H, Lee YS, Kim JH.
    Cancer Gene Ther; 2005 Jan 22; 12(1):61-71. PubMed ID: 15375379
    [Abstract] [Full Text] [Related]

  • 18. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC, Wang Y, Hallden G, Brooks G, Francis J, Lemoine NR, Kirn D.
    Gene Ther; 2005 Sep 22; 12(17):1333-46. PubMed ID: 15920462
    [Abstract] [Full Text] [Related]

  • 19. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.
    Cancer Gene Ther; 2002 May 22; 9(5):453-63. PubMed ID: 11961668
    [Abstract] [Full Text] [Related]

  • 20. Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor.
    Cho WK, Seong YR, Lee YH, Kim MJ, Hwang KS, Yoo J, Choi S, Jung CR, Im DS.
    Mol Ther; 2004 Nov 22; 10(5):938-49. PubMed ID: 15509511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.